Turn Therapeutics (TTRX) Income from Continuing Operations (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Income from Continuing Operations of 1196464.0 in Q1 2026, up 45.1% quarter-over-quarter from 2179395.0 in Q4 2025, and down 215.0% on a YoY basis from 1040419.68 in Q1 2025.
Turn Therapeutics (TTRX) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Turn Therapeutics' Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 1196464.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 215.0% year-over-year to 1196464.0; the TTM figure through Mar 2026 stood at 5664135.0 (changed N/A YoY), while the FY2025 annual figure was 5829065.0, down 229.62% from the prior year.
- Income from Continuing Operations was 1196464.0 for Q1 2026 at Turn Therapeutics, up from 2179395.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 323130.0 in Q4 2024 to a low of 2179395.0 in Q4 2025.
- Historically, Income from Continuing Operations has averaged 1108951.17 across 3 years, with a median of 931453.0 in 2024.
- Biggest YoY gain for Income from Continuing Operations was 186.36% in 2025; the steepest drop was 574.46% in 2025.
- A 3-year view of Income from Continuing Operations shows it stood at 323130.0 in 2024, then slumped by 574.46% to 2179395.0 in 2025, then soared by 45.1% to 1196464.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1196464.0 (Q1 2026), 2179395.0 (Q4 2025), and 1908444.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.80 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.40 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 Mn |
| Dec 31, 2025 | -2.18 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Mar 31, 2025 | -379,832.00 |
| Dec 31, 2024 | -323,130.00 |
| Sep 30, 2024 | -666,442.00 |